Finance
FDA fast-tracks psychedelic drug research following Trump executive order
It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.
C
CNBC
April 24, 2026·1 min de lecture
GM
FinanceIt's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.
Article original
FDA fast-tracks psychedelic drug research following Trump executive order
Publié par CNBC